About us

Kowa Company, Ltd.

The Kowa Group was founded in 1894, selling cotton fabric in Japan. From these humble beginnings, we have grown into a global enterprise with a diverse business portfolio. Kowa Company Ltd. is at the core of the Group, focussing mainly in the fields of textiles, machinery, construction materials, pharmaceuticals, medical equipment and products aimed at energy conservation and the environment.

Kowa Pharmaceutical Europe Co. Ltd.

In 1947, the privately-held multinational company Kowa Company, Ltd. of Nagoya, Japan, established its pharmaceutical division in order to research, develop, manufacture and market over-the-counter (OTC) drugs, healthcare products, prescription medicines and medical devices.

In 2000, Kowa Company, Ltd. expanded its global presence by establishing Kowa Pharmaceutical Europe Co. Ltd. This represented a significant step forward in the company’s vision of creating a global pharmaceutical organisation.

The first pharmaceutical product launched by Kowa Pharmaceutical Europe Co. Ltd. was Livazo® (pitavastatin), a potent HMG-CoA reductase inhibitor (statin) for the treatment of primary hyperlipidemia and combined (mixed) dyslipidemia.

Our mission

The pharmaceutical industry exists in an ever-changing landscape that presents constant challenges and opportunities in equal measure. At Kowa, we believe in employing dedicated professional people who are committed to our inspiring company values and challenging business goals, so together we can deliver a world-class service to our customers. It is our mission therefore to:

  • Develop and commercialise safe, effective, and high-quality pharmaceutical and medical device products
  • Put customer-focus at the heart of our business and provide the highest level of customer support
  • Continually innovate and challenge our thinking to deliver the best service that we can
  • Ensure we hire, develop and keep the very best people throughout our business infrastructure
  • Always conduct business with honesty, professionalism and integrity

“innovation through collaboration”

Our people

Passionate, professional people with the highest integrity have made Kowa the company that it is today, enabling us to continually deliver the quality service that we are dedicated to providing. Kowa Pharmaceutical Europe Co. Ltd. are committed to providing high value work in the following areas:

  • Business development
  • Sales and marketing

For enquires please telephone +44 (0) 118 944 3800 or contact us

“taking on the challenges of today, to build a better future for tomorrow”

Our world

We are very proud of the success that Kowa has enjoyed over the last hundred years through expansion in a number of our business’s and their product developments. Whilst we remain passionate about delivering on our future growth opportunities, we are very aware of our global environmental responsibilities. We therefore demand from each of our group’s member companies a commitment to untiring efforts towards sustainable development, and to achieving harmony between their future growth aspirations and global environmental preservation.

Visit kowa.co.jp to find out more

“with an eye on the earth… and the future”

Report adverse event

Kowa routinely monitors the safety of all its medicines. This includes review of safety data from clinical studies, and collection of reports and cases of adverse events for marketed products.

Patients and Volunteers in clinical trials reporting an adverse event must contact the investigator.

For specific medical information requests please visit the relevant product page to get in touch.

For the reporting of Livazo adverse events within Europe Union please contact local distributor or Recordati

For the reporting of Livazo adverse events within Middle East and North Africa (MENA) please contact...

Contact us

    I confirm I have read and accept the terms of the Privacy policy